ENGLEWOOD, Colo., July 1,
2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI),
an innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, stroke rehabilitation, cardiac monitoring and
neurological diagnostics, today announced it has been included
in the Russell 2000 Index following reconstitution of Russell
indices on June 28th. Zynex will be officially listed on the
Index when the markets open on Monday July
1, 2019.
Thomas Sandgaard, founder and CEO
of Zynex, commented "We are pleased to be added to the Russell 2000
Index, effectively increasing Zynex's visibility and public
awareness within the investment community. As we continue to
execute our growth strategy, we believe our inclusion in this index
will serve as a valuable tool to help broaden our shareholder base
and further our goal of advancing our products in the pain and
rehabilitation markets."
Membership in the small-cap Russell 2000® Index means
automatic inclusion in the Russell 3000® Index, as well as
appropriate growth and value style indexes. The Russell
3000® Index encompasses the 3,000 largest U.S.-traded stocks
by objective, market-capitalization rankings and style attributes.
This weighted index by market capitalization was constructed to
provide a comprehensive barometer of the broad market and it now
represents approximately 98 percent of the investable U.S. equity
market. The Russell Global Indexes reflect the performance of over
10,000 securities in 47 countries. Membership in these indexes is
updated annually and remains in place for one year.
ABOUT ZYNEX
Zynex, founded in 1996, markets and sells its own design of
electrotherapy medical devices used for pain management and
rehabilitation; and the company's proprietary NeuroMove device
designed to help recovery of stroke and spinal cord injury
patients. Zynex is also developing a new blood volume monitor for
use in hospitals and surgery centers.
For additional information, please visit: zynex.com.
ZYNEX INVESTOR RELATIONS CONTACT:
Amato and Partners, LLC
100 Park Avenue, 16th Floor
New York, NY 10017
(212) 430-0360
admin@amatoandpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/zynex-included-in-the-russell-2000-index-300878278.html
SOURCE Zynex